Founded with a mission to revolutionize cancer treatment, Embolx is a medical device startup specializing in the development and manufacturing of innovative embolization microcatheters. Their core products, the Sniper® Balloon Occlusion Microcatheter and the Soldier® High Flow Microcatheter, are designed for precision and performance in arterial embolization procedures. Embolx aims to enhance the effectiveness of cancer treatments by providing high-pressure and low-pressure solutions to medical professionals.
Notable affiliated individuals include Dr. Brian Kouri from Wake Forest Baptist Medical Center and Dr. Aaron Fischman, who have contributed to the clinical evidence supporting Embolx's technology. The company's key achievements include the successful deployment of their devices in numerous clinical settings, demonstrating significant improvements in targeted cancer treatment. Embolx's impact is marked by its commitment to advancing medical technology and improving patient outcomes in oncology.
